The University of Texas MD Anderson Cancer Center is committed to keeping our patients, our workforce members and our community safe throughout the 2019 novel coronavirus disease (COVID-19) pandemic. As part of our commitment, the institution is taking additional proactive measures to prevent the introduction or spread of COVID-19 at any of our campuses.
MD Anderson is:
Requiring quarantine for new patients traveling from...
New findings from researchers at The University of Texas MD Anderson Cancer Center about how some cancer cells become “addicted” to glucose...
Treating T cells harvested from a patient with a combination of an epigenetic drug and a cytokine while expanding the cells in the lab re-programs...
Medical experts have always known myelin, the protective coating of nerve cells, to be metabolically inert. A study led by The University of Texas MD Anderson Cancer Center has found that myelin is surprisingly dynamic, a discovery that has implications for treatment of multiple sclerosis and a type of myelin damage caused by some chemotherapy drugs, often referred to as “chemobrain.” Chemobrain can occur in up to 70 percent of patients...
A study conducted by researchers at The University of Texas MD Anderson Cancer Center demonstrated acceptable toxicity and anti-tumor activity...
The University of Texas MD Anderson Cancer Center is preparing to return to normal operations on Monday morning, March 2, after operating...